Dextera Surgical (DXTR) Stock Price, News & Analysis

Company Overview

Dextera Surgical Inc., formerly Cardica, Inc., designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its MicroCutter 5/80 is a commercially available cartridge-based microcutter device with approximately five millimeter shaft diameter, over 80 degrees of articulation, and an approximately 30 millimeter staple line cleared for specified indications for use in the United States, and in the European Union (EU) for a range of indications for use. It designs, manufactures and markets automated anastomotic systems used by surgeons to perform anastomoses during on- or off-pump coronary artery bypass graft procedures and these products include the C-Port xA system, the C-Port Flex A system and the PAS-Port Proximal Anastomosis System.

Key Stats

• Today's Range: $0.04 to $0.06
• 50-Day Range: N/A
• 52-Week Range: $0.02 to $0.80
• Volume: 1.49 million shs
• Average Volume: 423,525 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DXTR Stock Analysis - Frequently Asked Questions

How were Dextera Surgical's earnings last quarter?

Dextera Surgical (NASDAQ:DXTR) released its quarterly earnings data on Thursday, November, 9th. The medical instruments supplier reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.02. The medical instruments supplier had revenue of $0.69 million for the quarter, compared to analyst estimates of $0.62 million.

What other stocks do shareholders of Dextera Surgical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Dextera Surgical investors own include Conatus Pharmaceuticals (CNAT), (CASC) (CASC), Vaxart (VXRT), LadRx (CYTR), Synthetic Biologics (SYN), Delcath Systems (DCTHD) and Rexahn Pharmaceuticals (REXN).

Company Calendar

• Last Earnings: 11/09/2017
• Today: 2/22/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:DXTR
• CUSIP: N/A
• CIK: 1178104
• Web: www.dexterasurgical.com
• Phone: +1-650-3649975
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A